129 related articles for article (PubMed ID: 22391421)
1. Anti-LRP/LR-specific antibody IgG1-iS18 significantly reduces adhesion and invasion of metastatic lung, cervix, colon and prostate cancer cells.
Omar A; Reusch U; Knackmuss S; Little M; Weiss SF
J Mol Biol; 2012 May; 419(1-2):102-9. PubMed ID: 22391421
[TBL] [Abstract][Full Text] [Related]
2. Anti-LRP/LR-specific antibody IgG1-iS18 impedes adhesion and invasion of pancreatic cancer and neuroblastoma cells.
Rebelo TM; Chetty CJ; Ferreira E; Weiss SF
BMC Cancer; 2016 Nov; 16(1):917. PubMed ID: 27884119
[TBL] [Abstract][Full Text] [Related]
3. Invasion of tumorigenic HT1080 cells is impeded by blocking or downregulating the 37-kDa/67-kDa laminin receptor.
Zuber C; Knackmuss S; Zemora G; Reusch U; Vlasova E; Diehl D; Mick V; Hoffmann K; Nikles D; Fröhlich T; Arnold GJ; Brenig B; Wolf E; Lahm H; Little M; Weiss S
J Mol Biol; 2008 May; 378(3):530-9. PubMed ID: 18387633
[TBL] [Abstract][Full Text] [Related]
4. Adhesion and Invasion of Breast and Oesophageal Cancer Cells Are Impeded by Anti-LRP/LR-Specific Antibody IgG1-iS18.
Khumalo T; Reusch U; Knackmuss S; Little M; Veale RB; Weiss SF
PLoS One; 2013; 8(6):e66297. PubMed ID: 23823499
[TBL] [Abstract][Full Text] [Related]
5. Anti-LRP/LR specific antibody IgG1-iS18 impedes adhesion and invasion of liver cancer cells.
Chetty C; Khumalo T; Da Costa Dias B; Reusch U; Knackmuss S; Little M; Weiss SF
PLoS One; 2014; 9(5):e96268. PubMed ID: 24798101
[TBL] [Abstract][Full Text] [Related]
6. IgG1-iS18 impedes the adhesive and invasive potential of early and late stage malignant melanoma cells.
Munien C; Rebelo TM; Ferreira E; Weiss SF
Exp Cell Res; 2017 Feb; 351(2):135-141. PubMed ID: 28118986
[TBL] [Abstract][Full Text] [Related]
7. Anti-LRP/LR specific antibody IgG1-iS18 significantly impedes adhesion and invasion in early and late stage colorectal carcinoma cells.
Vania L; Chetty CJ; Ferreira E; Weiss SFT
Mol Med; 2016 Oct; 22():664-673. PubMed ID: 27611822
[TBL] [Abstract][Full Text] [Related]
8. Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor.
Omar A; Jovanovic K; Da Costa Dias B; Gonsalves D; Moodley K; Caveney R; Mbazima V; Weiss SF
Expert Opin Ther Pat; 2011 Jan; 21(1):35-53. PubMed ID: 21110766
[TBL] [Abstract][Full Text] [Related]
9. Cellular prion protein/laminin receptor: distribution in adult central nervous system and characterization of an isoform associated with a subtype of cortical neurons.
Baloui H; von Boxberg Y; Vinh J; Weiss S; Rossier J; Nothias F; Stettler O
Eur J Neurosci; 2004 Nov; 20(10):2605-16. PubMed ID: 15548204
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen).
Blumenthal RD; Hansen HJ; Goldenberg DM
Cancer Res; 2005 Oct; 65(19):8809-17. PubMed ID: 16204051
[TBL] [Abstract][Full Text] [Related]
11. Patented therapeutic approaches targeting LRP/LR for cancer treatment.
Vania L; Morris G; Otgaar TC; Bignoux MJ; Bernert M; Burns J; Gabathuse A; Singh E; Ferreira E; Weiss SFT
Expert Opin Ther Pat; 2019 Dec; 29(12):987-1009. PubMed ID: 31722579
[No Abstract] [Full Text] [Related]
12. Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo.
Yu J; Qian H; Li Y; Wang Y; Zhang X; Liang X; Fu M; Lin C
Gynecol Oncol; 2007 Aug; 106(2):400-6. PubMed ID: 17512576
[TBL] [Abstract][Full Text] [Related]
13. The laminin alpha 1 chain Ile-Lys-Val-Ala-Val (IKVAV)-containing peptide promotes liver colonization by human colon cancer cells.
Bresalier RS; Schwartz B; Kim YS; Duh QY; Kleinman HK; Sullam PM
Cancer Res; 1995 Jun; 55(11):2476-80. PubMed ID: 7758002
[TBL] [Abstract][Full Text] [Related]
14. Anti-LRP/LR specific antibody IgG1-iS18 and knock-down of LRP/LR by shRNAs rescue cells from Aβ42 induced cytotoxicity.
Da Costa Dias B; Jovanovic K; Gonsalves D; Moodley K; Reusch U; Knackmuss S; Penny C; Weinberg MS; Little M; Weiss SF
Sci Rep; 2013; 3():2702. PubMed ID: 24048171
[TBL] [Abstract][Full Text] [Related]
15. Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity.
Naidoo K; Malindisa ST; Otgaar TC; Bernert M; Da Costa Dias B; Ferreira E; Reusch U; Knackmuss S; Little M; Weiss SF; Letsolo BT
PLoS One; 2015; 10(11):e0141618. PubMed ID: 26545108
[TBL] [Abstract][Full Text] [Related]
16. LRP/LR specific antibody IgG1-iS18 impedes neurodegeneration in Alzheimer's disease mice.
Ferreira E; Bignoux MJ; Otgaar TC; Tagliatti N; Jovanovic K; Letsolo BT; Weiss SFT
Oncotarget; 2018 Jun; 9(43):27059-27073. PubMed ID: 29930750
[TBL] [Abstract][Full Text] [Related]
17. 37-kDa laminin receptor precursor mediates GnRH-II-induced MMP-2 expression and invasiveness in ovarian cancer cells.
Poon SL; Klausen C; Hammond GL; Leung PC
Mol Endocrinol; 2011 Feb; 25(2):327-38. PubMed ID: 21193558
[TBL] [Abstract][Full Text] [Related]
18. Novel patented therapeutic approaches targeting the 37/67 kDa laminin receptor for treatment of cancer and Alzheimer's disease.
Jovanovic K; Chetty CJ; Khumalo T; Da Costa Dias B; Ferreira E; Malindisa ST; Caveney R; Letsolo BT; Weiss SF
Expert Opin Ther Pat; 2015 May; 25(5):567-82. PubMed ID: 25747044
[TBL] [Abstract][Full Text] [Related]
19. LRP/LR Antibody Mediated Rescuing of Amyloid-β-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease.
Pinnock EC; Jovanovic K; Pinto MG; Ferreira E; Dias Bda C; Penny C; Knackmuss S; Reusch U; Little M; Schatzl HM; Weiss SF
J Alzheimers Dis; 2016; 49(3):645-57. PubMed ID: 26484914
[TBL] [Abstract][Full Text] [Related]
20. Stearate inhibits human tumor cell invasion.
Singh RK; Hardy RW; Wang MH; Williford J; Gladson CL; McDonald JM; Siegal GP
Invasion Metastasis; 1995; 15(3-4):144-55. PubMed ID: 8621270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
